|
1
|
Lenz G and Staudt LM: Aggressive
lymphomas. N Engl J Med. 362:1417–1429. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Teras LR, DeSantis CE, Cerhan JR, Morton
LM, Jemal A and Flowers CR: 2016 US lymphoid malignancy statistics
by world health organization subtypes. CA Cancer J Clin.
66:443–459. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fisher RI, Gaynor ER, Dahlberg S, Oken MM,
Grogan TM, Mize EM, Glick JH, Coltman CA Jr and Miller TP:
Comparison of a standard regimen (CHOP) with three intensive
chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J
Med. 328:1002–1006. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pfreundschuh M, Schubert J, Ziepert M,
Schmits R, Mohren M, Lengfelder E, Reiser M, Nickenig C, Clemens M,
Peter N, et al: Six versus eight cycles of bi-weekly CHOP-14 with
or without rituximab in elderly patients with aggressive CD20+
B-cell lymphomas: A randomised controlled trial (RICOVER-60).
Lancet Oncol. 9:105–116. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lohr JG, Stojanov P, Lawrence MS, Auclair
D, Chapuy B, Sougnez C, Cruz-Gordillo P, Knoechel B, Asmann YW,
Slager SL, et al: Discovery and prioritization of somatic mutations
in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.
Proc Natl Acad Sci. 109:3879–3884. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Reddy A, Zhang J, Davis NS, Moffitt AB,
Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-
Lindsberg ML, et al: Genetic and functional drivers of diffuse
large B cell lymphoma. Cell. 171:481–494.e15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chapuy B, Stewart C, Dunford AJ, Kim J,
Kamburov A, Redd RA, Lawrence MS, Roemer MGM, Li AJ, Ziepert M, et
al: Molecular subtypes of diffuse large B cell lymphoma are
associated with distinct pathogenic mechanisms and outcomes. Nat
Med. 24:679–690. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ld W, Dw P, Jones S, Lin J, Sjöblom T,
Leary RJ, Shen D, Boca SM, Barber T, Ptak J, et al: The genomic
landscapes of human breast and colorecta l cancers. Science.
318:1108–1113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hoadley KA, Yau C, Hinoue T, Wolf DM,
Lazar AJ, Drill E, Shen R, Taylor AM, Cherniack AD, Thorsson V, et
al: Cell-of- origin patterns dominate the molecular classification
of 10,000 tumors from 33 types of cancer. Cell. 173:291–304.e6.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Y, Cunningham F, Rios D, McLaren WM,
Smith J, Pritchard B, Spudich GM, Brent S, Kulesha E, Marin- Garcia
P, et al: Ensembl variation resources. BMC Genomics. 11:2932010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tamborero D, Gonzalez-Perez A and
Lopez-Bigas N: OncodriveCLUST: Exploiting the positional clustering
of somatic mutations to identify cancer genes. Bioinformatics.
29:2238–2244. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gonzalez-Perez A and Lopez-Bigas N:
Functional impact bias reveals cancer drivers. Nucleic Acids Res.
40:e1692012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dong C, Guo Y, Yang H, He Z, Liu X and
Wang K: iCAGES: Integrated CAncer GEnome score for comprehensively
prioritizing driver genes in personal cancer genomes. Genome Med.
8:1352016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hua X, Xu H, Yang Y, Zhu J, Liu P and Lu
Y: DrGaP: A powerful tool for identifying driver genes and pathways
in cancer sequencing studies. Am J Hum Genet. 93:439–451. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Y, Sun J and Zhao M: ONGene: A
literature-based database for human oncogenes. J Genet Genomics.
44:2016–2018. 2016.
|
|
16
|
Zhao M, Sun J and Zhao Z: TSGene: A web
resource for tumor suppressor genes. Nucleic Acids Res. 41:970–976.
2013. View Article : Google Scholar
|
|
17
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ogata H, Goto S, Sato K, Fujibuchi W, Bono
H and Kanehisa M: KEGG: Kyoto encyclopedia of genes and genomes.
Nucleic Acids Res. 27:29–34. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang DW, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carbone PP, Kaplan HS, Musshoff K,
Smithers DW and Tubiana M: Report of the committee on Hodgkin's
disease staging classification. Cancer Res. 31:1860–1861.
1971.PubMed/NCBI
|
|
22
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45((D1)): D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mermel CH, Schumacher SE, Hill B, Meyerson
ML, Beroukhim R and Getz G: GISTIC2.0 facilitates sensitive and
confident localization of the targets of focal somatic copy-number
alteration in human cancers. Genome Biol. 12:R412011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Warnes G, Bolker B, Bonebakker L,
Gentleman R, Huber W, Liaw A, Lumley T, Mächler MM and Steffen AM:
gplots: Various R programming tools for plotting data. R package
version. 2:https://www.researchgate.net/publication/303186599_gplots_Various_R_programming_tools_for_plotting_dataMay–2005
|
|
27
|
Stine R: An introduction to bootstrap
methods: Examples and ideas. Sociol Methods Res. 18:243–291. 1989.
View Article : Google Scholar
|
|
28
|
Fox J: Cox proportional-hazards regression
for survival data the cox proportional-hazards model. An R and
S-PLUS companion to applied regression. 2002:1–18. 2002.
|
|
29
|
Greenman C, Stephens P, Smith R, Dalgliesh
GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C,
et al: Patterns of somatic mutation in human cancer genomes.
Nature. 446:153–158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Puente XS, Pinyol M, Quesada V, Conde L,
Ordóñez GR, Villamor N, Escaramis G, Jares P, Beà S, González-Díaz
M, et al: Whole-genome sequencing identifies recurrent mutations in
chronic lymphocytic leukaemia. Nature. 475:101–105. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chapman MA, Lawrence MS, Keats JJ,
Cibulskis K, Sougnez C, Schinzel AC, Harview CL, Brunet JP, Ahmann
GJ, Adli M, et al: Initial genome sequencing and analysis of
multiple myeloma. Nature. 471:467–472. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kolodner RD and Marsischky GT: Eukaryotic
DNA mismatch repair. Curr Opin Genet Dev. 9:89–96. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lawrence MS, Stojanov P, Polak P, Kryukov
GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH,
Roberts SA, et al: Mutational heterogeneity in cancer and the
search for new cancer-associated genes. Nature. 499:214–218. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dees ND, Zhang Q, Kandoth C, Wendl MC,
Schierding W, Koboldt DC, Mooney TB, Callaway MB, Dooling D, Mardis
ER, et al: MuSiC: Identifying mutational significance in cancer
genomes. Genome Res. 22:1589–1598. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yoshimura M, Ishizawa J, Ruvolo V, Dilip
A, Quintás-Cardama A, McDonnell TJ, Neelapu SS, Kwak LW, Shacham S,
Kauffman M, et al: Induction of p53-mediated transcription and
apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma.
Cancer Sci. 105:795–801. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gao W, Lu C, Chen L and Keohavong P:
Overexpression of CRM1: A characteristic feature in a transformed
phenotype of lung carcinogenesis and a molecular target for lung
cancer adjuvant therapy. J Thorac Oncol. 10:815–825. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou F, Qiu W, Yao R, Xiang J, Sun X, Liu
S, Lv J and Yue L: CRM1 is a novel independent prognostic factor
for the poor prognosis of gastric carcinomas. Med Oncol.
30:7262013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ishizawa J, Kojima K, Hail N Jr, Tabe Y
and Andreeff M: Expression, function, and targeting of the nuclear
exporter chromosome region maintenance 1 (CRM1) protein. Pharmacol
Ther. 153:25–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kojima K, Kornblau SM, Ruvolo V, Dilip A,
Duvvuri S, Davis RE, Zhang M, Wang Z, Coombes KR, Zhang N, et al:
Prognostic impact and targeting of CRM1 in acute myeloid leukemia.
Blood. 121:4166–4174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang WY, Yue L, Qiu WS, Wang LW, Zhou XH
and Sun YJ: Prognostic value of CRM1 in pancreas cancer. Clin
Invest Med. 32:E3152009. View Article : Google Scholar : PubMed/NCBI
|
